LIMK2 and neoplasm: PD-L2 knockdown was found to attenuate the migration and invasion of OS cells via the inhibition of RhoA-ROCK-LIMK2 signaling in vitro [35], which could be another role of PD-L2 in tumor cells rather than in immune cells.